This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

Up to €600 savings end in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
March 23–25, 2026
FIL (Feira Internacional de Lisboa), Lisbon, PortugalMarch 31 – April 1, 2026 | Digital Partnering

Martin Svorc
Director, Neurology & Immunology, Fertility Business Development at Merck KGaA
Speaker

Profile

Martin Svorc is a Director of Global Business Development at Merck, where he leads end-to-end deal execution for the Neurology & Immunology, and Fertility franchises. In addition to his transactional responsibilities, Martin serves as the AI Strategy & Enablement Lead for the business development unit. In this role, he focuses on the practical integration of AI tools to improve efficiency across the deal lifecycle, including target identification, evaluation, due diligence, negotiations, and alliance management. With over a decade of experience at Merck spanning global product launches and market expansion in Europe and APAC, Martin brings a pragmatic perspective to how biopharma teams can effectively leverage AI in their current workflows.

Agenda Sessions

  • Is AI at the helm of biopharma business development strategies?

    15:00